1. Introduction
The poultry industry is in the middle of an important transformation in response to shifting public perceptions about animal welfare and the voluntary and regulatory initiatives to promote it. Two areas of interest are housing and production systems. Egg production is becoming more common in large and heavily populated cage-free environments around the world [
1]. There is a growing consensus about the importance of producing more robust laying hens that can adapt to these evolving management styles, different housing systems, and environmental challenges, while maintaining good egg production and health [
2,
3,
4]. With these industry changes, exposure to infectious disease is more common [
5]. The tools available to prevent and control diseases in poultry are limited due to cost, large numbers of birds, inefficiency of anti-viral agents and risk of developing antimicrobial resistance [
6], and they mainly rely on a fully functional and well-developed immune response. The immune system of poultry is complex; it includes both innate and adaptative responses that are composed of cellular and molecular effectors that coordinate to recognize, label, and destroy infectious organisms [
7]. Antibodies (immunoglobulins) are a key humoral immune protein with multiple defensive functions [
7,
8]. The antibody proteins are produced by B-lymphocytes, and they bind to foreign molecules to induce numerous defensive effects, including neutralization of pathogen function, labeling of pathogens for attack by defensive cells, and facilitating defensive molecule binding to pathogens (e.g., complement proteins) [
7,
9].
Natural antibodies (NAbs) are a sub-category of immunoglobulins that are part of the innate immune response [
10,
11,
12]. They are expressed prior to immune challenge or infection and provide protection while the adaptative immune system develops; therefore, they are beneficial in the protection against infection, and they represent plausible indicators to determine susceptibility/resistance [
7,
10,
11,
12,
13]. Importantly, NAbs are thought to facilitate the adaptive immune response by supporting pathogen recognition, tagging (opsonization), and antigen presentation [
14,
15,
16,
17,
18]. Adaptive antibodies (AAbs) are the best-studied immunoglobins. These molecules are produced following a pathogen encounter, through a series of regulatory steps that include pathogen phagocytosis, antigen presentation, regulatory T-lymphocyte signaling, and stimulation of B-lymphocytes to produce antigen-specific antibodies with high specificity [
7]. This reflects the adaptive immune response with increased specificity and effectiveness of immune defense. Adaptive antibodies are the target of vaccination, with the goal to stimulate the production of AAbs specific to select pathogens prior to any infection.
Animals are known to differ in susceptibility to diseases, and a part of this variation can be explained by host genetics [
19,
20,
21]. Antibody levels are known to be controlled by multiple genes [
22]; therefore, selection may improve antibody-mediated immunity [
23]. The direct measurement of disease resistance phenotypes is costly and requires long-term experimental challenges or large and accurate data collection in the field for endemic diseases. Fulton et al. [
24] showed that selection against Marek’s disease-induced mortality can be effective if performed consistently over extended periods of time. However, disease resistance phenotypes are not available on breeding stocks kept in bio-secure environments; therefore, alternative proxy traits should be explored to enable genetic selection for disease resistance. Genetic variation exists for antibody response after vaccination; however, the literature estimates of heritability are low to moderate, with values ranging from 0.04 to 0.31 depending on the population, method of estimation, and time span after vaccination [
25,
26,
27,
28,
29]. In a study including IBD, IBV, and NDV following the challenge and using a variety of methods, the estimates of heritability ranged from 0.0 to 0.58 for IBD, 0.0 to 0.58 for IBV, and 0.0 to 0.37 for NDV [
30].
Natural antibody levels have been shown to have a genetic component. The literature estimates of heritability are not abundant [
29,
31,
32,
33]; some studies focusing on anti-KLH responses have found values of between 0.05 and 0.28 for the general response or for specific immunoglobulins (IgT, IgM, IgA, and IgG), indicating a range of values similar to the ones reported for response to vaccination above. ivergent selection for low or high Nab levels to keyhole limpet hemocyanin (KLH) resulted in lines with differential responses [
34]. Similar divergently selected populations have been studied to gain insights into the genetics of antibody response and to identify QTL regions [
35,
36] and candidate genes [
37] that impact the immune response. A candidate gene (TLR1A) with a strong effect on the level of IgM was identified in a White Leghorn population [
38]. The studies were, however, limited in genomic resolution to a 60 k SNP chip and were also limited to a single artificially created or existing chicken line. Such results should be confirmed across commercially used lines for the possible implementation in breeding programs designed to produce commercial birds. It must also be noted that the high antibody response to SRBC line was shown to result in more resistance for some but not all disease challenges [
23]. Therefore, it may be necessary to consider more than a single antigen to achieve better overall disease resistance. Wondmeneh et al. [
39] showed opposing effects of increased antibody levels on survival in two layer lines (positive in ISA Brown but negative in the Ethiopian Horo breed), which suggests that the effects may be line-dependent. To overcome these limitations, the objective of this study was to analyze the genetic background of natural antibodies binding KLH, OVA, and PHA and adaptive antibodies binding IBD, IBV, NDV, and REO in eight lines of elite layer chickens, which represent three breeds used for commercial egg production, White Leghorn (WL), Rhode Island Red (RIR), and White Plymouth Rock (WPR). To the best of our knowledge, no previous research paper has evaluated the genetic basis for multiple NAbs and AAbs in the same animals, which will make the study herein unique in the chicken immunogenetic literature. The genotype information was obtained from low pass sequences (1× and 4×) and from 54 K Axiom SNP arrays.
4. Discussion
In the study herein, we evaluated the genetic basis for innate (natural) and induced (adaptive) antibodies in chickens using elite egg production lines from three chicken breeds (Rhode Island Red, White Leghorn, and White Plymouth Rock). Natural antibodies were measured using enzyme-linked immunosorbent assays with external antigens (KLH and PHA) and an autoantigen (OVA). Adaptive antibody responses were measured after vaccination for common chicken viral diseases (IBD, IBV, NVD, REO) using commercial ELISA kits. Data utilized for this study included eight lines representing three breeds (RIR, WL and WPR) and multiple generations (
Table 1). For some generation–line combinations both male and female information was available. Levels of antibodies in vaccinated birds against viral diseases were variable across generations, lines and, in some cases, sexes. Antibody responses after vaccination against common viral diseases tended to be higher than those for natural antibodies. Average values (across lines) for the vaccines were 3.02, 1.97, 4.94, and 1.43 for IBD, IBV, NDV, and REO, respectively; 0.91 and 0.62 for naive antigens for chickens KLH and PHA; and 1.27 for OVA, an egg albumen autoantigen.
The principles of vaccination and the mechanisms that they induce to promote immune responses are well-known; for a general review, see [
48]. The use of vaccines in poultry production is well-established [
49]; for a review of the specific vaccines against poultry viruses of global and commercial importance, including the ones studied herein, see [
50]. The antibody response to vaccination in chickens has been well-studied (e.g., [
30,
51]). In our study, there were significant differences in antibody responses to each antigen among the lines. The brown-egg lines tended to have greater antibody responses against IBD (WPR), IBV (WPR), NVD (WPR) and REO (RIR, WPR) antibodies than the WL (white-egg) lines. This could be related to higher levels of genetic variation in immune related genes in brown-egg lines compared to WL as indicated by higher number of haplotypes observed for the chicken Major Histocompability Complex (MHC) (unpublished). The magnitude of the heritability estimates was quite erratic, and no general conclusion could be reached. Estimates ranged from zero to low to high depending on the line and vaccine (
Table 2,
Table 3,
Table 4 and
Table 5). This can be in part due to the data structure and the limited information contained in the data to properly estimate genetic parameters, as was evident from the large standard errors associated with heritability estimates for all disease cases. However, if we consider the average values across lines, the pedigree heritability estimates were 0.10, 0.22, 0.17 and 0.14 for antibodies against IBD, IBV, NDV and REO, respectively. The corresponding genomic estimates were 0.07, 0.15, 0.10 and 0.06, respectively. These results indicate that selecting for antibody responses to vaccination must be evaluated on a case-by-case basis. Literature estimates of heritability for antibody response after vaccination support low to moderate values and a wide range of values ranging from 0.04 to 0.31 depending on the population, method of estimation, and time span after vaccination [
25,
26,
27,
28,
29]. In a study including IBD, IBV, and NDV following challenge and using a variety of methods, estimates of heritability ranged from 0.0 to 0.58 for IBD, 0.0 to 0.58 for IBV and 0.0 to 0.37 for NDV [
30]. Our results were more consistent showing the presence of more between-population genetic variation than within-line (estimates of heritability) genetic variation for vaccine response, which may impact the design of breeding strategies targeting this trait.
Natural antibodies present with no known prior contact with a specific antigen are also studied in chickens. Parmentier et al. [
31] observed variations in anti-KLH and anti-OVA antibodies in chickens divergently selected for antibody response. Berghof et al. [
33] used chicks of the high and low NAb response lines and confirmed that selective breeding for high KLH-binding levels increased pathogen resistance. We detected significant differences among lines in levels of NAb specific for KLH, OVA and PHA, and found that brown-egg lines (WPR and RIR) showed higher anti-KLH antibody levels than the white-egg (WL) lines, as was the case for the adaptive antibody response after vaccination. This is not a generalized result. It is well-known that brown-egg type layers have higher MHC polymorphism than white-egg layers, and this could also contribute to a more robust immune defense. Response to vaccination can vary depending on many factors, including the route of administration. A recent study compared different vaccination regimens and chicken breeds in three trials [
52]. The study showed varying immune response levels. For instance, Barred Rock layers and Rhode Island Red pullets showed a strong immune response in both serum and egg yolk when vaccinated intramuscularly and subcutaneously with a KLH–enterobactin conjugate. However, the opposite occurred following intradermic application, for which White Leghorn showed a stronger response. So, as in the case of responses to vaccination, some genetic variation in Nabs is present in commercial layer populations. The magnitude of heritability estimates for Nab response herein was also variable and no solid conclusion could be reached. Estimates ranged from zero to low to high depending on the line and antigen (
Table 6,
Table 7 and
Table 8). Several estimates were close to the lowest boundary of the parameter space and may indicate that not enough information was contained in the data for some antigen-line combinations. As for the case of vaccine responses, there were large standard errors associated with heritability estimates for NAb levels. However, if we consider the average values across lines, the pedigree heritability estimates were 0.21, 0.15 and 0.06 for antibodies anti-KLH, anti-OVA and anti-PHA, respectively. The corresponding genomic estimates were 0.16, 0.15 and 0.08, respectively. So overall, these results indicate that these traits are relatively heritable and can be incorporated in a selection strategy to improve general immunity; however, implementation must be evaluated for each population and antigen. Published research showing estimates of heritability for NAb expression is not extensive; however, a few papers show results that indicate relatively low to intermediate values. Berghof et al. [
32] found estimates ranging from 0.05 to 0.17 in males and females for titers of anti-KLH antibodies in a purebred White Leghorn layer line, corresponding estimates pooling all data for specific IgT, IgM, IgA and IgG were 0.12, 0.14, 0.10 and 0.07, respectively. Using the same genetic line, ref. [
53] reported estimates of heritability for total antibody concentrations of IgT, IgM, IgA, and IgG of 0.08, 0.23, 0.22, and 0.06, respectively. Berghof et al. [
33] documented the results from a study successfully increasing resistance to avian pathogenic
Escherichia coli by selection for specific natural antibodies against KLH using the same WL line mentioned above [
31]. Their results supported the hypothesis that levels of NAb might be used as an indicator trait to genetically improve disease resistance in egg-laying chickens. A more recent study described genetic and non-genetic factors affecting antibody response against KLH and generated in response to NDV vaccine on chicken populations from Africa [
29]. Their heritability estimates for anti-KLH IgM, IgG, and IgA were 0.28, 0.14, and 0.07, respectively. Based on these results, they suggested that selection for genetic improvement of general and specific immunity was possible and would potentially improve disease resistance. However, the authors cautioned that an appropriate approach would require combining traits related to natural and acquired immunity in a multiple trait implementation as they found negative genetic correlations between KLH–nAbs and NDV–IgG of −0.26 to −0.9 [
29].
Pathway analysis confirmed that genes with SNPs identified as associated with antibody levels were enriched with immune related protein classes. For joined analyses of NAbs and AAbs significant gene overrepresentations were found for RIR and WL breeds, with the top enriched classes being for defense/immunity protein and the immunoglobulin receptor superfamily. This result clearly indicates the alignment between the observed phenotypes, the genome-wide analyses, and the gene representations. Birds respond to stimulation with specific pathogens via vaccination against a variety of viral diseases (IBD, IVB, NDV and REO) or to other molecules known to interact with natural antibodies (KLH, OVA and PHA) by triggering genes responsible for coding the immune-related proteins. However, when gene enrichment was explored separately for NAbs and AAbs, similar gene overrepresentations were found for the RIR and WL breeds, mainly in terms of the expression of natural antibodies, which dominated the gene expression space. On the contrary, for WPR lines only significant overrepresentation of genes in response to induced antibodies were found. This result indicates that the nature of genetic responses against natural and induced antigens vary across lines of chickens selected for egg production.